Reduction of miR-106b correlated with decreased human lung cancer cell proliferations, as well as up-regulations of CDKN1A mRNA expressions, and the respective protein product p21, a predicted target of miR-106b (TargetScanHuman, http://www.targetscan.org/vert_61). This evidence concerns the gene CDKN1A and lung cancer.